nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP19A1—uterine cancer	0.197	0.521	CbGaD
Melatonin—ESR1—uterine cancer	0.181	0.479	CbGaD
Melatonin—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0987	0.252	CbGbCtD
Melatonin—ESR1—Progesterone—uterine cancer	0.0654	0.167	CbGbCtD
Melatonin—CYP1B1—Progesterone—uterine cancer	0.0654	0.167	CbGbCtD
Melatonin—MPO—Carboplatin—uterine cancer	0.0524	0.134	CbGbCtD
Melatonin—CYP1A1—Progesterone—uterine cancer	0.0287	0.0732	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—uterine cancer	0.02	0.0509	CbGbCtD
Melatonin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0174	0.0445	CbGbCtD
Melatonin—CYP2C19—Progesterone—uterine cancer	0.0139	0.0354	CbGbCtD
Melatonin—CYP1A2—Progesterone—uterine cancer	0.0128	0.0327	CbGbCtD
Melatonin—CYP2C9—Progesterone—uterine cancer	0.0115	0.0295	CbGbCtD
Melatonin—CYP1A2—Etoposide—uterine cancer	0.00574	0.0146	CbGbCtD
Melatonin—CYP19A1—corpus luteum—uterine cancer	0.00454	0.0638	CbGeAlD
Melatonin—CALR—oviduct—uterine cancer	0.0044	0.0618	CbGeAlD
Melatonin—CALR—exocrine gland—uterine cancer	0.00254	0.0357	CbGeAlD
Melatonin—CYP19A1—semen—uterine cancer	0.00213	0.0299	CbGeAlD
Melatonin—EPX—female reproductive system—uterine cancer	0.00185	0.026	CbGeAlD
Melatonin—CALM2—semen—uterine cancer	0.00184	0.0258	CbGeAlD
Melatonin—CALM1—semen—uterine cancer	0.00183	0.0257	CbGeAlD
Melatonin—ASMT—female reproductive system—uterine cancer	0.00153	0.0215	CbGeAlD
Melatonin—CALR—myometrium—uterine cancer	0.00141	0.0198	CbGeAlD
Melatonin—IDO1—female reproductive system—uterine cancer	0.0014	0.0197	CbGeAlD
Melatonin—ESR1—oviduct—uterine cancer	0.00136	0.0191	CbGeAlD
Melatonin—CALM2—oviduct—uterine cancer	0.00135	0.019	CbGeAlD
Melatonin—MPO—artery—uterine cancer	0.00127	0.0178	CbGeAlD
Melatonin—CALR—epithelium—uterine cancer	0.00111	0.0155	CbGeAlD
Melatonin—CALR—uterine cervix—uterine cancer	0.0011	0.0154	CbGeAlD
Melatonin—CALR—smooth muscle tissue—uterine cancer	0.00106	0.015	CbGeAlD
Melatonin—CALR—decidua—uterine cancer	0.00104	0.0147	CbGeAlD
Melatonin—CALR—renal system—uterine cancer	0.00103	0.0144	CbGeAlD
Melatonin—CALR—endometrium—uterine cancer	0.000991	0.0139	CbGeAlD
Melatonin—CALR—mammalian vulva—uterine cancer	0.000959	0.0135	CbGeAlD
Melatonin—CALR—uterus—uterine cancer	0.000913	0.0128	CbGeAlD
Melatonin—CALM2—artery—uterine cancer	0.000893	0.0126	CbGeAlD
Melatonin—CALM1—artery—uterine cancer	0.000889	0.0125	CbGeAlD
Melatonin—CALR—female reproductive system—uterine cancer	0.000821	0.0115	CbGeAlD
Melatonin—IDO1—lymph node—uterine cancer	0.000819	0.0115	CbGeAlD
Melatonin—NQO2—myometrium—uterine cancer	0.000794	0.0112	CbGeAlD
Melatonin—CALM2—exocrine gland—uterine cancer	0.000779	0.0109	CbGeAlD
Melatonin—CALM1—exocrine gland—uterine cancer	0.000775	0.0109	CbGeAlD
Melatonin—CALR—female gonad—uterine cancer	0.000747	0.0105	CbGeAlD
Melatonin—CALR—vagina—uterine cancer	0.000743	0.0104	CbGeAlD
Melatonin—NQO2—uterine cervix—uterine cancer	0.000618	0.00869	CbGeAlD
Melatonin—MT3—lymph node—uterine cancer	0.000609	0.00856	CbGeAlD
Melatonin—NQO2—decidua—uterine cancer	0.000589	0.00828	CbGeAlD
Melatonin—NQO2—renal system—uterine cancer	0.000578	0.00813	CbGeAlD
Melatonin—NQO2—endometrium—uterine cancer	0.000559	0.00786	CbGeAlD
Melatonin—CALM3—myometrium—uterine cancer	0.00055	0.00772	CbGeAlD
Melatonin—NQO2—mammalian vulva—uterine cancer	0.000541	0.0076	CbGeAlD
Melatonin—NQO2—uterus—uterine cancer	0.000515	0.00724	CbGeAlD
Melatonin—CALR—lymph node—uterine cancer	0.00048	0.00675	CbGeAlD
Melatonin—MPO—epithelium—uterine cancer	0.00048	0.00674	CbGeAlD
Melatonin—NQO2—female reproductive system—uterine cancer	0.000463	0.00651	CbGeAlD
Melatonin—MPO—renal system—uterine cancer	0.000445	0.00625	CbGeAlD
Melatonin—ESR1—myometrium—uterine cancer	0.000434	0.0061	CbGeAlD
Melatonin—CALM2—myometrium—uterine cancer	0.000432	0.00606	CbGeAlD
Melatonin—CALM1—myometrium—uterine cancer	0.00043	0.00604	CbGeAlD
Melatonin—CALM3—uterine cervix—uterine cancer	0.000428	0.00601	CbGeAlD
Melatonin—NQO2—female gonad—uterine cancer	0.000421	0.00592	CbGeAlD
Melatonin—NQO2—vagina—uterine cancer	0.000419	0.00589	CbGeAlD
Melatonin—CALM3—smooth muscle tissue—uterine cancer	0.000416	0.00584	CbGeAlD
Melatonin—CALM3—decidua—uterine cancer	0.000407	0.00572	CbGeAlD
Melatonin—CALM3—endometrium—uterine cancer	0.000387	0.00543	CbGeAlD
Melatonin—CALM3—mammalian vulva—uterine cancer	0.000374	0.00526	CbGeAlD
Melatonin—CALM3—uterus—uterine cancer	0.000356	0.00501	CbGeAlD
Melatonin—SLC22A8—renal system—uterine cancer	0.000356	0.005	CbGeAlD
Melatonin—CYP1B1—smooth muscle tissue—uterine cancer	0.000353	0.00496	CbGeAlD
Melatonin—CYP19A1—endometrium—uterine cancer	0.000352	0.00494	CbGeAlD
Melatonin—CYP1B1—decidua—uterine cancer	0.000346	0.00487	CbGeAlD
Melatonin—ESR1—epithelium—uterine cancer	0.000341	0.00479	CbGeAlD
Melatonin—CYP1B1—renal system—uterine cancer	0.00034	0.00478	CbGeAlD
Melatonin—CALM2—epithelium—uterine cancer	0.000339	0.00476	CbGeAlD
Melatonin—ESR1—uterine cervix—uterine cancer	0.000338	0.00475	CbGeAlD
Melatonin—CALM1—epithelium—uterine cancer	0.000337	0.00474	CbGeAlD
Melatonin—CALM2—uterine cervix—uterine cancer	0.000336	0.00472	CbGeAlD
Melatonin—CALM1—uterine cervix—uterine cancer	0.000334	0.0047	CbGeAlD
Melatonin—ESR1—smooth muscle tissue—uterine cancer	0.000328	0.00461	CbGeAlD
Melatonin—CALM2—smooth muscle tissue—uterine cancer	0.000326	0.00459	CbGeAlD
Melatonin—CALM1—smooth muscle tissue—uterine cancer	0.000325	0.00456	CbGeAlD
Melatonin—CYP19A1—uterus—uterine cancer	0.000324	0.00455	CbGeAlD
Melatonin—ESR1—decidua—uterine cancer	0.000322	0.00452	CbGeAlD
Melatonin—CALM2—decidua—uterine cancer	0.00032	0.0045	CbGeAlD
Melatonin—CALM1—decidua—uterine cancer	0.000318	0.00448	CbGeAlD
Melatonin—ESR1—renal system—uterine cancer	0.000316	0.00444	CbGeAlD
Melatonin—CALM2—renal system—uterine cancer	0.000314	0.00441	CbGeAlD
Melatonin—CALM1—renal system—uterine cancer	0.000313	0.00439	CbGeAlD
Melatonin—ESR1—endometrium—uterine cancer	0.000306	0.00429	CbGeAlD
Melatonin—CALM2—endometrium—uterine cancer	0.000304	0.00427	CbGeAlD
Melatonin—CYP1B1—uterus—uterine cancer	0.000303	0.00426	CbGeAlD
Melatonin—CALM1—endometrium—uterine cancer	0.000302	0.00425	CbGeAlD
Melatonin—CALM2—mammalian vulva—uterine cancer	0.000294	0.00413	CbGeAlD
Melatonin—CALM1—mammalian vulva—uterine cancer	0.000292	0.00411	CbGeAlD
Melatonin—CALM3—female gonad—uterine cancer	0.000292	0.0041	CbGeAlD
Melatonin—CYP19A1—female reproductive system—uterine cancer	0.000291	0.00409	CbGeAlD
Melatonin—CALM3—vagina—uterine cancer	0.00029	0.00407	CbGeAlD
Melatonin—ESR1—uterus—uterine cancer	0.000282	0.00396	CbGeAlD
Melatonin—CALM2—uterus—uterine cancer	0.00028	0.00393	CbGeAlD
Melatonin—CALM1—uterus—uterine cancer	0.000279	0.00391	CbGeAlD
Melatonin—CYP1B1—female reproductive system—uterine cancer	0.000272	0.00383	CbGeAlD
Melatonin—NQO2—lymph node—uterine cancer	0.000271	0.00381	CbGeAlD
Melatonin—CYP19A1—female gonad—uterine cancer	0.000265	0.00372	CbGeAlD
Melatonin—CYP1A1—epithelium—uterine cancer	0.000259	0.00364	CbGeAlD
Melatonin—CYP1A1—uterine cervix—uterine cancer	0.000257	0.00361	CbGeAlD
Melatonin—ESR1—female reproductive system—uterine cancer	0.000253	0.00356	CbGeAlD
Melatonin—CALM2—female reproductive system—uterine cancer	0.000252	0.00354	CbGeAlD
Melatonin—CALM1—female reproductive system—uterine cancer	0.00025	0.00352	CbGeAlD
Melatonin—CYP1B1—female gonad—uterine cancer	0.000248	0.00348	CbGeAlD
Melatonin—CYP1A2—renal system—uterine cancer	0.000244	0.00342	CbGeAlD
Melatonin—CYP1A1—renal system—uterine cancer	0.00024	0.00338	CbGeAlD
Melatonin—ESR1—female gonad—uterine cancer	0.00023	0.00324	CbGeAlD
Melatonin—CALM2—female gonad—uterine cancer	0.000229	0.00322	CbGeAlD
Melatonin—ESR1—vagina—uterine cancer	0.000229	0.00322	CbGeAlD
Melatonin—CALM1—female gonad—uterine cancer	0.000228	0.0032	CbGeAlD
Melatonin—CALM2—vagina—uterine cancer	0.000228	0.0032	CbGeAlD
Melatonin—CALM1—vagina—uterine cancer	0.000227	0.00318	CbGeAlD
Melatonin—CYP1A1—mammalian vulva—uterine cancer	0.000225	0.00316	CbGeAlD
Melatonin—CYP2C19—vagina—uterine cancer	0.000216	0.00304	CbGeAlD
Melatonin—CYP1A1—uterus—uterine cancer	0.000214	0.00301	CbGeAlD
Melatonin—MPO—lymph node—uterine cancer	0.000209	0.00293	CbGeAlD
Melatonin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000207	0.00233	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.000206	0.00233	CcSEcCtD
Melatonin—Dyspepsia—Progesterone—uterine cancer	0.000205	0.00232	CcSEcCtD
Melatonin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000205	0.00232	CcSEcCtD
Melatonin—Hypocalcaemia—Epirubicin—uterine cancer	0.000204	0.00231	CcSEcCtD
Melatonin—Lacrimation increased—Epirubicin—uterine cancer	0.000203	0.00229	CcSEcCtD
Melatonin—Nocturia—Epirubicin—uterine cancer	0.000202	0.00228	CcSEcCtD
Melatonin—Erythema—Dactinomycin—uterine cancer	0.000202	0.00228	CcSEcCtD
Melatonin—Gastrointestinal disorder—Progesterone—uterine cancer	0.000201	0.00227	CcSEcCtD
Melatonin—Fatigue—Progesterone—uterine cancer	0.000201	0.00227	CcSEcCtD
Melatonin—Pain—Progesterone—uterine cancer	0.000199	0.00225	CcSEcCtD
Melatonin—CYP1A1—female reproductive system—uterine cancer	0.000192	0.0027	CbGeAlD
Melatonin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.00217	CcSEcCtD
Melatonin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000191	0.00216	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00019	0.00215	CcSEcCtD
Melatonin—Gastrointestinal pain—Progesterone—uterine cancer	0.00019	0.00215	CcSEcCtD
Melatonin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000189	0.00214	CcSEcCtD
Melatonin—Neck pain—Epirubicin—uterine cancer	0.000189	0.00214	CcSEcCtD
Melatonin—Hypocalcaemia—Doxorubicin—uterine cancer	0.000189	0.00214	CcSEcCtD
Melatonin—Lacrimation increased—Doxorubicin—uterine cancer	0.000188	0.00212	CcSEcCtD
Melatonin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000188	0.00212	CcSEcCtD
Melatonin—CALM3—lymph node—uterine cancer	0.000187	0.00263	CbGeAlD
Melatonin—Infestation NOS—Etoposide—uterine cancer	0.000187	0.00211	CcSEcCtD
Melatonin—Infestation—Etoposide—uterine cancer	0.000187	0.00211	CcSEcCtD
Melatonin—Nocturia—Doxorubicin—uterine cancer	0.000187	0.00211	CcSEcCtD
Melatonin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000186	0.0021	CcSEcCtD
Melatonin—CYP2C9—female reproductive system—uterine cancer	0.000185	0.0026	CbGeAlD
Melatonin—Abnormal dreams—Epirubicin—uterine cancer	0.000185	0.00209	CcSEcCtD
Melatonin—Abdominal pain—Progesterone—uterine cancer	0.000184	0.00208	CcSEcCtD
Melatonin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000182	0.00206	CcSEcCtD
Melatonin—Stomatitis—Etoposide—uterine cancer	0.000182	0.00206	CcSEcCtD
Melatonin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000182	0.00206	CcSEcCtD
Melatonin—Salivary hypersecretion—Epirubicin—uterine cancer	0.000182	0.00205	CcSEcCtD
Melatonin—Leukopenia—Dactinomycin—uterine cancer	0.00018	0.00204	CcSEcCtD
Melatonin—Hepatobiliary disease—Etoposide—uterine cancer	0.000177	0.002	CcSEcCtD
Melatonin—Neck pain—Doxorubicin—uterine cancer	0.000175	0.00198	CcSEcCtD
Melatonin—CYP1A1—female gonad—uterine cancer	0.000175	0.00246	CbGeAlD
Melatonin—CYP1A1—vagina—uterine cancer	0.000174	0.00245	CbGeAlD
Melatonin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000172	0.00195	CcSEcCtD
Melatonin—Hypersensitivity—Progesterone—uterine cancer	0.000172	0.00194	CcSEcCtD
Melatonin—Abnormal dreams—Doxorubicin—uterine cancer	0.000171	0.00193	CcSEcCtD
Melatonin—CYP19A1—lymph node—uterine cancer	0.00017	0.00239	CbGeAlD
Melatonin—Mouth ulceration—Epirubicin—uterine cancer	0.000169	0.00191	CcSEcCtD
Melatonin—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000168	0.0019	CcSEcCtD
Melatonin—Asthenia—Progesterone—uterine cancer	0.000167	0.00189	CcSEcCtD
Melatonin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000167	0.00188	CcSEcCtD
Melatonin—Urinary tract disorder—Etoposide—uterine cancer	0.000166	0.00187	CcSEcCtD
Melatonin—Pruritus—Progesterone—uterine cancer	0.000165	0.00186	CcSEcCtD
Melatonin—Urethral disorder—Etoposide—uterine cancer	0.000164	0.00186	CcSEcCtD
Melatonin—Infection—Dactinomycin—uterine cancer	0.000163	0.00185	CcSEcCtD
Melatonin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000161	0.00182	CcSEcCtD
Melatonin—CYP1B1—lymph node—uterine cancer	0.000159	0.00224	CbGeAlD
Melatonin—Eye disorder—Etoposide—uterine cancer	0.000157	0.00177	CcSEcCtD
Melatonin—Mouth ulceration—Doxorubicin—uterine cancer	0.000157	0.00177	CcSEcCtD
Melatonin—Cardiac disorder—Etoposide—uterine cancer	0.000156	0.00176	CcSEcCtD
Melatonin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.00176	CcSEcCtD
Melatonin—Dizziness—Progesterone—uterine cancer	0.000154	0.00174	CcSEcCtD
Melatonin—Angiopathy—Etoposide—uterine cancer	0.000152	0.00172	CcSEcCtD
Melatonin—Immune system disorder—Etoposide—uterine cancer	0.000151	0.00171	CcSEcCtD
Melatonin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000151	0.00171	CcSEcCtD
Melatonin—Eczema—Epirubicin—uterine cancer	0.000151	0.00171	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00015	0.00169	CcSEcCtD
Melatonin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000149	0.00169	CcSEcCtD
Melatonin—ESR1—lymph node—uterine cancer	0.000148	0.00208	CbGeAlD
Melatonin—Vomiting—Progesterone—uterine cancer	0.000148	0.00167	CcSEcCtD
Melatonin—CALM2—lymph node—uterine cancer	0.000147	0.00207	CbGeAlD
Melatonin—Rash—Progesterone—uterine cancer	0.000147	0.00166	CcSEcCtD
Melatonin—Dermatitis—Progesterone—uterine cancer	0.000147	0.00166	CcSEcCtD
Melatonin—CALM1—lymph node—uterine cancer	0.000147	0.00206	CbGeAlD
Melatonin—Headache—Progesterone—uterine cancer	0.000146	0.00165	CcSEcCtD
Melatonin—Hot flush—Epirubicin—uterine cancer	0.000145	0.00164	CcSEcCtD
Melatonin—Menopausal symptoms—Epirubicin—uterine cancer	0.000144	0.00163	CcSEcCtD
Melatonin—Fatigue—Dactinomycin—uterine cancer	0.000142	0.0016	CcSEcCtD
Melatonin—Back pain—Etoposide—uterine cancer	0.000141	0.0016	CcSEcCtD
Melatonin—Pain—Dactinomycin—uterine cancer	0.000141	0.00159	CcSEcCtD
Melatonin—Muscle spasms—Etoposide—uterine cancer	0.00014	0.00159	CcSEcCtD
Melatonin—Eczema—Doxorubicin—uterine cancer	0.00014	0.00158	CcSEcCtD
Melatonin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00158	CcSEcCtD
Melatonin—Lethargy—Epirubicin—uterine cancer	0.000139	0.00157	CcSEcCtD
Melatonin—Nausea—Progesterone—uterine cancer	0.000138	0.00156	CcSEcCtD
Melatonin—Hyponatraemia—Epirubicin—uterine cancer	0.000136	0.00154	CcSEcCtD
Melatonin—Pain in extremity—Epirubicin—uterine cancer	0.000136	0.00154	CcSEcCtD
Melatonin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000135	0.00152	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—uterine cancer	0.000134	0.00152	CcSEcCtD
Melatonin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.00152	CcSEcCtD
Melatonin—Affect lability—Epirubicin—uterine cancer	0.000134	0.00151	CcSEcCtD
Melatonin—Migraine—Epirubicin—uterine cancer	0.000134	0.00151	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—uterine cancer	0.000133	0.00151	CcSEcCtD
Melatonin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.0015	CcSEcCtD
Melatonin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.0015	CcSEcCtD
Melatonin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000132	0.00149	CcSEcCtD
Melatonin—Vertigo—Etoposide—uterine cancer	0.000131	0.00148	CcSEcCtD
Melatonin—Leukopenia—Etoposide—uterine cancer	0.000131	0.00148	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—uterine cancer	0.00013	0.00147	CcSEcCtD
Melatonin—Mood swings—Epirubicin—uterine cancer	0.000129	0.00145	CcSEcCtD
Melatonin—Loss of consciousness—Etoposide—uterine cancer	0.000128	0.00145	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—uterine cancer	0.000128	0.00145	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—uterine cancer	0.000126	0.00143	CcSEcCtD
Melatonin—Hypertension—Etoposide—uterine cancer	0.000126	0.00142	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—uterine cancer	0.000126	0.00142	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—uterine cancer	0.000125	0.00142	CcSEcCtD
Melatonin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000125	0.00142	CcSEcCtD
Melatonin—Dry skin—Epirubicin—uterine cancer	0.000124	0.00141	CcSEcCtD
Melatonin—Chest pain—Etoposide—uterine cancer	0.000124	0.0014	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—uterine cancer	0.000124	0.0014	CcSEcCtD
Melatonin—Migraine—Doxorubicin—uterine cancer	0.000124	0.0014	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—uterine cancer	0.000124	0.0014	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000123	0.00139	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—uterine cancer	0.000123	0.00139	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—uterine cancer	0.000121	0.00137	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—uterine cancer	0.000121	0.00137	CcSEcCtD
Melatonin—Gastritis—Epirubicin—uterine cancer	0.00012	0.00136	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—uterine cancer	0.000119	0.00135	CcSEcCtD
Melatonin—Infection—Etoposide—uterine cancer	0.000118	0.00134	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—uterine cancer	0.000118	0.00133	CcSEcCtD
Melatonin—Thrombocytopenia—Etoposide—uterine cancer	0.000117	0.00132	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000116	0.00131	CcSEcCtD
Melatonin—Skin disorder—Etoposide—uterine cancer	0.000116	0.00131	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—uterine cancer	0.000115	0.0013	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—uterine cancer	0.000115	0.0013	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—uterine cancer	0.000114	0.00129	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—uterine cancer	0.000114	0.00128	CcSEcCtD
Melatonin—CYP1A1—lymph node—uterine cancer	0.000113	0.00158	CbGeAlD
Melatonin—Nasopharyngitis—Doxorubicin—uterine cancer	0.000112	0.00127	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—uterine cancer	0.000111	0.00126	CcSEcCtD
Melatonin—Paraesthesia—Etoposide—uterine cancer	0.000107	0.00121	CcSEcCtD
Melatonin—Weight increased—Epirubicin—uterine cancer	0.000107	0.00121	CcSEcCtD
Melatonin—Somnolence—Etoposide—uterine cancer	0.000106	0.0012	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—uterine cancer	0.000106	0.0012	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—uterine cancer	0.000105	0.00118	CcSEcCtD
Melatonin—Infestation—Epirubicin—uterine cancer	0.000105	0.00118	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—uterine cancer	0.000105	0.00118	CcSEcCtD
Melatonin—Rash—Dactinomycin—uterine cancer	0.000104	0.00117	CcSEcCtD
Melatonin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000103	0.00116	CcSEcCtD
Melatonin—Fatigue—Etoposide—uterine cancer	0.000103	0.00116	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—uterine cancer	0.000102	0.00115	CcSEcCtD
Melatonin—Pain—Etoposide—uterine cancer	0.000102	0.00115	CcSEcCtD
Melatonin—Haematuria—Epirubicin—uterine cancer	9.98e-05	0.00113	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—uterine cancer	9.9e-05	0.00112	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—uterine cancer	9.88e-05	0.00112	CcSEcCtD
Melatonin—Nausea—Dactinomycin—uterine cancer	9.77e-05	0.0011	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—uterine cancer	9.74e-05	0.0011	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—uterine cancer	9.68e-05	0.00109	CcSEcCtD
Melatonin—Infestation—Doxorubicin—uterine cancer	9.68e-05	0.00109	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—uterine cancer	9.44e-05	0.00107	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—uterine cancer	9.41e-05	0.00106	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—uterine cancer	9.28e-05	0.00105	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—uterine cancer	9.23e-05	0.00104	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—uterine cancer	9.23e-05	0.00104	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—uterine cancer	9.21e-05	0.00104	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—uterine cancer	9.16e-05	0.00104	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—uterine cancer	8.78e-05	0.000993	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—uterine cancer	8.77e-05	0.000992	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—uterine cancer	8.72e-05	0.000986	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—uterine cancer	8.59e-05	0.00097	CcSEcCtD
Melatonin—Asthenia—Etoposide—uterine cancer	8.54e-05	0.000966	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—uterine cancer	8.54e-05	0.000966	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—uterine cancer	8.52e-05	0.000964	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—uterine cancer	8.52e-05	0.000963	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—uterine cancer	8.49e-05	0.000959	CcSEcCtD
Melatonin—Pruritus—Etoposide—uterine cancer	8.43e-05	0.000952	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—uterine cancer	8.23e-05	0.00093	CcSEcCtD
Melatonin—Erythema—Epirubicin—uterine cancer	8.18e-05	0.000925	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—uterine cancer	8.18e-05	0.000925	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—uterine cancer	8.12e-05	0.000918	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—uterine cancer	8.07e-05	0.000912	CcSEcCtD
Melatonin—Flatulence—Epirubicin—uterine cancer	8.06e-05	0.000911	CcSEcCtD
Melatonin—Tension—Epirubicin—uterine cancer	8.03e-05	0.000907	CcSEcCtD
Melatonin—Nervousness—Epirubicin—uterine cancer	7.94e-05	0.000898	CcSEcCtD
Melatonin—Back pain—Epirubicin—uterine cancer	7.91e-05	0.000894	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—uterine cancer	7.89e-05	0.000892	CcSEcCtD
Melatonin—Dizziness—Etoposide—uterine cancer	7.87e-05	0.00089	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—uterine cancer	7.86e-05	0.000889	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—uterine cancer	7.85e-05	0.000888	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—uterine cancer	7.71e-05	0.000871	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—uterine cancer	7.62e-05	0.000861	CcSEcCtD
Melatonin—Vomiting—Etoposide—uterine cancer	7.57e-05	0.000856	CcSEcCtD
Melatonin—Erythema—Doxorubicin—uterine cancer	7.57e-05	0.000855	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—uterine cancer	7.57e-05	0.000855	CcSEcCtD
Melatonin—Agitation—Epirubicin—uterine cancer	7.52e-05	0.00085	CcSEcCtD
Melatonin—Rash—Etoposide—uterine cancer	7.51e-05	0.000849	CcSEcCtD
Melatonin—Dermatitis—Etoposide—uterine cancer	7.5e-05	0.000848	CcSEcCtD
Melatonin—Headache—Etoposide—uterine cancer	7.46e-05	0.000843	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—uterine cancer	7.46e-05	0.000843	CcSEcCtD
Melatonin—Tension—Doxorubicin—uterine cancer	7.43e-05	0.000839	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—uterine cancer	7.35e-05	0.000831	CcSEcCtD
Melatonin—Vertigo—Epirubicin—uterine cancer	7.35e-05	0.000831	CcSEcCtD
Melatonin—Syncope—Epirubicin—uterine cancer	7.34e-05	0.000829	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—uterine cancer	7.32e-05	0.000828	CcSEcCtD
Melatonin—Back pain—Doxorubicin—uterine cancer	7.32e-05	0.000827	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—uterine cancer	7.28e-05	0.000822	CcSEcCtD
Melatonin—Palpitations—Epirubicin—uterine cancer	7.23e-05	0.000817	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—uterine cancer	7.19e-05	0.000813	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—uterine cancer	7.13e-05	0.000806	CcSEcCtD
Melatonin—Nausea—Etoposide—uterine cancer	7.07e-05	0.0008	CcSEcCtD
Melatonin—Hypertension—Epirubicin—uterine cancer	7.06e-05	0.000798	CcSEcCtD
Melatonin—Chest pain—Epirubicin—uterine cancer	6.96e-05	0.000787	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—uterine cancer	6.96e-05	0.000787	CcSEcCtD
Melatonin—Agitation—Doxorubicin—uterine cancer	6.95e-05	0.000786	CcSEcCtD
Melatonin—Anxiety—Epirubicin—uterine cancer	6.94e-05	0.000784	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.92e-05	0.000782	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—uterine cancer	6.81e-05	0.00077	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—uterine cancer	6.8e-05	0.000769	CcSEcCtD
Melatonin—Syncope—Doxorubicin—uterine cancer	6.79e-05	0.000767	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—uterine cancer	6.77e-05	0.000766	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—uterine cancer	6.69e-05	0.000756	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—uterine cancer	6.65e-05	0.000752	CcSEcCtD
Melatonin—Infection—Epirubicin—uterine cancer	6.63e-05	0.00075	CcSEcCtD
Melatonin—Shock—Epirubicin—uterine cancer	6.57e-05	0.000742	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—uterine cancer	6.55e-05	0.00074	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—uterine cancer	6.54e-05	0.000739	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—uterine cancer	6.53e-05	0.000739	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—uterine cancer	6.48e-05	0.000733	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—uterine cancer	6.44e-05	0.000728	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—uterine cancer	6.44e-05	0.000728	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—uterine cancer	6.42e-05	0.000726	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.4e-05	0.000723	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—uterine cancer	6.3e-05	0.000712	CcSEcCtD
Melatonin—Infection—Doxorubicin—uterine cancer	6.14e-05	0.000694	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.08e-05	0.000687	CcSEcCtD
Melatonin—Shock—Doxorubicin—uterine cancer	6.08e-05	0.000687	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—uterine cancer	6.06e-05	0.000685	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—uterine cancer	6.05e-05	0.000684	CcSEcCtD
Melatonin—Insomnia—Epirubicin—uterine cancer	6.04e-05	0.000682	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—uterine cancer	6e-05	0.000678	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—uterine cancer	5.99e-05	0.000678	CcSEcCtD
Melatonin—Somnolence—Epirubicin—uterine cancer	5.93e-05	0.000671	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—uterine cancer	5.88e-05	0.000664	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—uterine cancer	5.76e-05	0.000651	CcSEcCtD
Melatonin—Fatigue—Epirubicin—uterine cancer	5.76e-05	0.000651	CcSEcCtD
Melatonin—Pain—Epirubicin—uterine cancer	5.71e-05	0.000645	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.63e-05	0.000636	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—uterine cancer	5.59e-05	0.000631	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—uterine cancer	5.55e-05	0.000627	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—uterine cancer	5.49e-05	0.000621	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—uterine cancer	5.46e-05	0.000617	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—uterine cancer	5.44e-05	0.000615	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.33e-05	0.000603	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—uterine cancer	5.33e-05	0.000602	CcSEcCtD
Melatonin—Pain—Doxorubicin—uterine cancer	5.28e-05	0.000597	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—uterine cancer	5.28e-05	0.000596	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—uterine cancer	5.05e-05	0.000571	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—uterine cancer	4.92e-05	0.000556	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—uterine cancer	4.88e-05	0.000552	CcSEcCtD
Melatonin—Asthenia—Epirubicin—uterine cancer	4.79e-05	0.000541	CcSEcCtD
Melatonin—Pruritus—Epirubicin—uterine cancer	4.72e-05	0.000534	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—uterine cancer	4.55e-05	0.000514	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—uterine cancer	4.43e-05	0.000501	CcSEcCtD
Melatonin—Dizziness—Epirubicin—uterine cancer	4.41e-05	0.000499	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—uterine cancer	4.37e-05	0.000494	CcSEcCtD
Melatonin—Vomiting—Epirubicin—uterine cancer	4.24e-05	0.00048	CcSEcCtD
Melatonin—Rash—Epirubicin—uterine cancer	4.21e-05	0.000476	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—uterine cancer	4.21e-05	0.000475	CcSEcCtD
Melatonin—Headache—Epirubicin—uterine cancer	4.18e-05	0.000473	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—uterine cancer	4.08e-05	0.000462	CcSEcCtD
Melatonin—Nausea—Epirubicin—uterine cancer	3.97e-05	0.000448	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—uterine cancer	3.93e-05	0.000444	CcSEcCtD
Melatonin—Rash—Doxorubicin—uterine cancer	3.89e-05	0.00044	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—uterine cancer	3.89e-05	0.00044	CcSEcCtD
Melatonin—Headache—Doxorubicin—uterine cancer	3.87e-05	0.000437	CcSEcCtD
Melatonin—Nausea—Doxorubicin—uterine cancer	3.67e-05	0.000415	CcSEcCtD
Melatonin—CALM2—Hemostasis—KRAS—uterine cancer	4.66e-06	6.58e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—KRAS—uterine cancer	4.66e-06	6.58e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SOCS3—uterine cancer	4.61e-06	6.51e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SOCS3—uterine cancer	4.61e-06	6.51e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CDH1—uterine cancer	4.57e-06	6.45e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—MTHFR—uterine cancer	4.57e-06	6.45e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN2B—uterine cancer	4.56e-06	6.44e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.44e-06	6.26e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1R—uterine cancer	4.43e-06	6.25e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—PIK3CA—uterine cancer	4.43e-06	6.25e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CDH1—uterine cancer	4.43e-06	6.24e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CDH1—uterine cancer	4.43e-06	6.24e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—MTHFR—uterine cancer	4.43e-06	6.24e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—MTHFR—uterine cancer	4.43e-06	6.24e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN2B—uterine cancer	4.41e-06	6.23e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN2B—uterine cancer	4.41e-06	6.23e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—MTHFR—uterine cancer	4.34e-06	6.12e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KRAS—uterine cancer	4.34e-06	6.12e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.31e-06	6.08e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—STK11—uterine cancer	4.31e-06	6.08e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCL2—uterine cancer	4.29e-06	6.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1R—uterine cancer	4.29e-06	6.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1R—uterine cancer	4.29e-06	6.05e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—uterine cancer	4.28e-06	6.04e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—PIK3CA—uterine cancer	4.28e-06	6.04e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—PIK3CA—uterine cancer	4.28e-06	6.04e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.23e-06	5.97e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KRAS—uterine cancer	4.2e-06	5.92e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KRAS—uterine cancer	4.2e-06	5.92e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KRAS—uterine cancer	4.17e-06	5.88e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SMAD3—uterine cancer	4.17e-06	5.88e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—uterine cancer	4.14e-06	5.85e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—uterine cancer	4.14e-06	5.85e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—HRAS—uterine cancer	4.1e-06	5.78e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTEN—uterine cancer	4.07e-06	5.74e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.05e-06	5.71e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KRAS—uterine cancer	4.03e-06	5.69e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KRAS—uterine cancer	4.03e-06	5.69e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SMAD3—uterine cancer	4.03e-06	5.69e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SMAD3—uterine cancer	4.03e-06	5.69e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CXCL8—uterine cancer	4.01e-06	5.65e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—PIK3CA—uterine cancer	3.99e-06	5.62e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FGFR2—uterine cancer	3.97e-06	5.61e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—HRAS—uterine cancer	3.96e-06	5.59e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—HRAS—uterine cancer	3.96e-06	5.59e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTEN—uterine cancer	3.92e-06	5.53e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—EP300—uterine cancer	3.88e-06	5.48e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CXCL8—uterine cancer	3.88e-06	5.47e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CXCL8—uterine cancer	3.88e-06	5.47e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—ERBB2—uterine cancer	3.86e-06	5.45e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.86e-06	5.44e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—PIK3CA—uterine cancer	3.86e-06	5.44e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—PIK3CA—uterine cancer	3.86e-06	5.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FGFR2—uterine cancer	3.84e-06	5.42e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FGFR2—uterine cancer	3.84e-06	5.42e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—PIK3CA—uterine cancer	3.83e-06	5.4e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.83e-06	5.4e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—EP300—uterine cancer	3.74e-06	5.28e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ERBB2—uterine cancer	3.73e-06	5.27e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ERBB2—uterine cancer	3.73e-06	5.27e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—PIK3CA—uterine cancer	3.7e-06	5.22e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—PIK3CA—uterine cancer	3.7e-06	5.22e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HRAS—uterine cancer	3.69e-06	5.2e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.68e-06	5.2e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—STK11—uterine cancer	3.68e-06	5.2e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—AKT1—uterine cancer	3.62e-06	5.1e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CDKN1B—uterine cancer	3.57e-06	5.04e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ERBB2—uterine cancer	3.57e-06	5.04e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HRAS—uterine cancer	3.57e-06	5.03e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HRAS—uterine cancer	3.57e-06	5.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—ERBB2—uterine cancer	3.56e-06	5.03e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—MTHFR—uterine cancer	3.55e-06	5.01e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HRAS—uterine cancer	3.54e-06	5e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—AKT1—uterine cancer	3.5e-06	4.94e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—AKT1—uterine cancer	3.5e-06	4.94e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CDKN1B—uterine cancer	3.46e-06	4.88e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CDKN1B—uterine cancer	3.46e-06	4.88e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.46e-06	4.88e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—ERBB2—uterine cancer	3.45e-06	4.86e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—ERBB2—uterine cancer	3.45e-06	4.86e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HRAS—uterine cancer	3.43e-06	4.83e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HRAS—uterine cancer	3.43e-06	4.83e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ESR1—uterine cancer	3.4e-06	4.8e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CXCL8—uterine cancer	3.39e-06	4.78e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTNNB1—uterine cancer	3.38e-06	4.76e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CDKN1B—uterine cancer	3.31e-06	4.67e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CDKN1B—uterine cancer	3.3e-06	4.66e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.3e-06	4.65e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PTEN—uterine cancer	3.29e-06	4.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ESR1—uterine cancer	3.29e-06	4.64e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ESR1—uterine cancer	3.29e-06	4.64e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTNNB1—uterine cancer	3.27e-06	4.61e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTNNB1—uterine cancer	3.27e-06	4.61e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—AKT1—uterine cancer	3.26e-06	4.59e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—MTHFR—uterine cancer	3.24e-06	4.57e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—NRAS—uterine cancer	3.21e-06	4.53e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1B—uterine cancer	3.19e-06	4.5e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1B—uterine cancer	3.19e-06	4.5e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PTEN—uterine cancer	3.18e-06	4.49e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PTEN—uterine cancer	3.18e-06	4.49e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—AKT1—uterine cancer	3.15e-06	4.44e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—AKT1—uterine cancer	3.15e-06	4.44e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EP300—uterine cancer	3.14e-06	4.43e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.13e-06	4.42e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—uterine cancer	3.13e-06	4.41e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—AKT1—uterine cancer	3.13e-06	4.41e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—uterine cancer	3.12e-06	4.4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—NRAS—uterine cancer	3.11e-06	4.39e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—NRAS—uterine cancer	3.11e-06	4.39e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTEN—uterine cancer	3.05e-06	4.3e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTEN—uterine cancer	3.04e-06	4.29e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EP300—uterine cancer	3.04e-06	4.28e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EP300—uterine cancer	3.04e-06	4.28e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—AKT1—uterine cancer	3.03e-06	4.27e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—AKT1—uterine cancer	3.03e-06	4.27e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—uterine cancer	3.02e-06	4.25e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—uterine cancer	3.02e-06	4.25e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCL2—uterine cancer	2.99e-06	4.22e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—uterine cancer	2.94e-06	4.15e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—uterine cancer	2.94e-06	4.15e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—uterine cancer	2.94e-06	4.14e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EP300—uterine cancer	2.91e-06	4.1e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EP300—uterine cancer	2.9e-06	4.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL2—uterine cancer	2.9e-06	4.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL2—uterine cancer	2.9e-06	4.09e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.87e-06	4.05e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.85e-06	4.03e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—uterine cancer	2.84e-06	4.01e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—uterine cancer	2.84e-06	4.01e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EP300—uterine cancer	2.8e-06	3.96e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EP300—uterine cancer	2.8e-06	3.96e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—uterine cancer	2.77e-06	3.9e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—uterine cancer	2.77e-06	3.9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—uterine cancer	2.77e-06	3.9e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—uterine cancer	2.75e-06	3.88e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—uterine cancer	2.72e-06	3.84e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—uterine cancer	2.71e-06	3.82e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—uterine cancer	2.7e-06	3.81e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—uterine cancer	2.68e-06	3.77e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—uterine cancer	2.68e-06	3.77e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—uterine cancer	2.62e-06	3.7e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—uterine cancer	2.62e-06	3.7e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—uterine cancer	2.54e-06	3.59e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	2.54e-06	3.59e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—uterine cancer	2.53e-06	3.57e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—uterine cancer	2.5e-06	3.52e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—uterine cancer	2.46e-06	3.47e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—uterine cancer	2.46e-06	3.47e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	2.46e-06	3.47e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	2.46e-06	3.47e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—uterine cancer	2.44e-06	3.45e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—uterine cancer	2.44e-06	3.45e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.44e-06	3.44e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—EP300—uterine cancer	2.43e-06	3.42e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—uterine cancer	2.41e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—uterine cancer	2.41e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—uterine cancer	2.41e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—uterine cancer	2.37e-06	3.34e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—uterine cancer	2.35e-06	3.32e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—EP300—uterine cancer	2.35e-06	3.31e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—EP300—uterine cancer	2.35e-06	3.31e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—uterine cancer	2.35e-06	3.31e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—uterine cancer	2.34e-06	3.3e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—uterine cancer	2.33e-06	3.29e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—uterine cancer	2.32e-06	3.28e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—uterine cancer	2.31e-06	3.26e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—EP300—uterine cancer	2.3e-06	3.25e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—uterine cancer	2.29e-06	3.23e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—uterine cancer	2.29e-06	3.23e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—uterine cancer	2.27e-06	3.21e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—uterine cancer	2.27e-06	3.21e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—uterine cancer	2.26e-06	3.19e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—uterine cancer	2.26e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—uterine cancer	2.26e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—uterine cancer	2.25e-06	3.17e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—uterine cancer	2.25e-06	3.17e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—uterine cancer	2.24e-06	3.15e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—uterine cancer	2.24e-06	3.15e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—uterine cancer	2.18e-06	3.08e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—uterine cancer	2.15e-06	3.03e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—uterine cancer	2.15e-06	3.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—uterine cancer	2.14e-06	3.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—uterine cancer	2.13e-06	3e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—uterine cancer	2.11e-06	2.98e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—uterine cancer	2.11e-06	2.98e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—uterine cancer	2.08e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—uterine cancer	2.08e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—uterine cancer	2.08e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—uterine cancer	2.08e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—uterine cancer	2.07e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—uterine cancer	2.07e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—uterine cancer	2.06e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—uterine cancer	2.06e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EP300—uterine cancer	2.03e-06	2.86e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—uterine cancer	2.01e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—uterine cancer	2.01e-06	2.83e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—uterine cancer	1.99e-06	2.81e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—uterine cancer	1.98e-06	2.8e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—uterine cancer	1.98e-06	2.79e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EP300—uterine cancer	1.96e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EP300—uterine cancer	1.96e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—uterine cancer	1.92e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—uterine cancer	1.92e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—uterine cancer	1.92e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—uterine cancer	1.9e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—uterine cancer	1.9e-06	2.68e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—EP300—uterine cancer	1.88e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—uterine cancer	1.86e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—uterine cancer	1.86e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—uterine cancer	1.84e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—uterine cancer	1.84e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—uterine cancer	1.83e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—uterine cancer	1.83e-06	2.59e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—uterine cancer	1.8e-06	2.54e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—uterine cancer	1.8e-06	2.53e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—uterine cancer	1.76e-06	2.48e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—uterine cancer	1.75e-06	2.47e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—uterine cancer	1.74e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—uterine cancer	1.74e-06	2.45e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—EP300—uterine cancer	1.72e-06	2.42e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—uterine cancer	1.7e-06	2.4e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—uterine cancer	1.69e-06	2.39e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—uterine cancer	1.69e-06	2.39e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—uterine cancer	1.63e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—uterine cancer	1.58e-06	2.23e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—uterine cancer	1.58e-06	2.23e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—uterine cancer	1.54e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—uterine cancer	1.5e-06	2.12e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—EP300—uterine cancer	1.47e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—uterine cancer	1.47e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—uterine cancer	1.45e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—uterine cancer	1.45e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—uterine cancer	1.45e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—uterine cancer	1.42e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—uterine cancer	1.42e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—uterine cancer	1.4e-06	1.98e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—uterine cancer	1.4e-06	1.98e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.39e-06	1.97e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—uterine cancer	1.39e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—uterine cancer	1.39e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—uterine cancer	1.34e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—uterine cancer	1.34e-06	1.9e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.27e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—uterine cancer	1.23e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—uterine cancer	1.19e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—uterine cancer	1.19e-06	1.67e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—uterine cancer	1.14e-06	1.61e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.09e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—uterine cancer	1.04e-06	1.46e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—uterine cancer	8.87e-07	1.25e-05	CbGpPWpGaD
